Four details:
1. Amazon in March 2020 announced the $20 million investment in the AWS Diagnostic Development initiative, which allows research institutions and private companies to use the cloud platform to support their COVID-19 research.
2. Beginning April 12, AWS is broadening the scope of the project to three new areas: early disease detection to identify outbreaks at individual and community level; prognosis to better understand disease trajectory and public health genomics to strengthen viral genome sequencing.
3. AWS will use the remaining $12 million in funds on COVID-19 projects as well as work focused on other infectious diseases. In the first phase of the program, AWS helped 87 organizations and awarded $8 million for projects including molecular tests for antibodies, diagnostic imaging and wearables.
4. AWS will give priority consideration to applications received before July 31, according to the blog post.
More articles on digital transformation:
9 recent Apple partnerships in the last 6 months: A timeline
UPMC, Advocate Aurora join hospital-at-home initiative backed by Amazon, Intermountain and Ascension
Primary care startup Firefly Health bags $40M to launch new health plan benefit
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
